Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy.
Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy. Eur J Gastroenterol Hepatol. 2015 Oct; 27(10):1154-60.